1. Z-11 trial and rethinking axillary reverse mapping

   • Masakuni Noguchi

   Editorial 11 January 2015 Pages: 99 - 100

2. HER2-directed therapy: current treatment options for HER2-positive breast cancer

   • Shahid Ahmed
   • Amer Sami
   • Jim Xiang

   Review Article 30 January 2015 Pages: 101 - 116

   

3. Prognostic impact of CD10 expression in clinical outcome of invasive breast carcinoma

   • Thi-Ngoc Diem Vo
   • Eiji Mekata
   • Tohru Tani

   Original Article 11 April 2013 Pages: 117 - 128

   

4. Visual assessment of Ki67 at a glance is an easy method to exclude many luminal-type breast cancers from counting 1000 cells

   • Akira I. Hida
   • Yumi Oshiro
   • Takuya Moriya

   Original Article 31 March 2013 Pages: 129 - 134

   

5. Utility of one-step nucleic acid amplification (OSNA) assay in detecting breast cancer metastases of sentinel lymph nodes in a Chinese population

   • Dali Li
   • Xiaoli Xu
   • Daren Shi

   Original Article 21 March 2013 Pages: 135 - 140

6. Prognostic impact of Ki-67 labeling indices with 3 different cutoff values, histological grade, and nuclear grade in hormone-receptor-positive, HER2-negative, node-negative invasive breast cancers

   • Makiko Ono
   • Hitoshi Tsuda
   • Yasuhiro Fujiwara

   Original Article 13 April 2013 Pages: 141 - 152

   

7. Interobserver variability of ultrasound elastography and the ultrasound BI-RADS lexicon of breast lesions

   • Chang Suk Park
   • Sung Hun Kim
   • Hyun Seouk Jung

   Original Article 13 April 2013 Pages: 153 - 160

   

8. Divisional role of quantitative HER2 testing in breast cancer

   • Mutsuko Yamamoto-Ibusuki
   • Yutaka Yamamoto
   • Hirotaka Iwase

   Original Article 20 April 2013 Pages: 161 - 171

   

9. Breast cancer screening and the changing population pyramid of Japan

   • Ken Uchida
   • Hitoshi Ohashi
   • Hiroshi Takeyama

   Original Article 30 April 2013 Pages: 172 - 176

   

10. A combination of aprepitant, palonosetron, and dexamethasone prevents emesis associated with anthracycline-containing regimens for patients with breast cancer. A retrospective study

    • Yoshie Nakayama
    • Yoshinori Ito
    • Kiyohiko Hatake

    Original Article 08 May 2013 Pages: 177 - 184

    

11. Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer

    • Tatsuya Yoshioka
    • Mitsuchika Hosoda
    • Hiroko Yamashita

    Original Article 05 May 2013 Pages: 185 - 191

    

12. Efficacy, safety, pharmacokinetics and biomarker findings in patients with HER2-positive advanced or metastatic breast cancer treated with lapatinib in combination with capecitabine: results from 51 Japanese patients treated in a clinical study

    • Hiroji Iwata
    • Hirofumi Fujii
    • Seigo Nakamura

    Original Article Open access 21 May 2013 Pages: 192 - 200

    

13. Malignant lymphoma of the breast in a male patient: ultrasound imaging features

    • Tatsuhiko Ikeda
    • Hiroko Bando
    • Hisato Hara

    Case Report 07 March 2012 Pages: 201 - 205

    

14. Metastatic breast carcinoma of the abdominal wall muscle: a case report

    • Akiko Ogiya
    • Kaoru Takahashi
    • Seiji Yamasaki

    Case Report 02 March 2012 Pages: 206 - 209